Anti-myeloma vaccine trial data…

At the beginning of April, Vaxil BioTherapeutics released the interim results from its Phase I and II vaccine trial in multiple myeloma patients. The full shebang is available online for free, so I don’t need to do much…commenting (though I probably will, hehe): http://goo.gl/ec1ZI The vaccine, called ImMucin, targets something called MUC1 (the “Muc” in “ImMucin”!) […]